Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer (original) (raw)

• Jemal A, Siegel R, Ward E et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66
  Article PubMed Google Scholar
• Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042–2054. doi:10.1056/NEJMra023075
  Article PubMed CAS Google Scholar
• Das PM, Singal R (2007) DNA methylation and cancer. J Clin Oncol 22:4632–4642. doi:10.1200/JCO.2004.07.151
  Article CAS Google Scholar
• Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683–692. doi:10.1016/j.cell.2007.01.029
  Article PubMed CAS Google Scholar
• Szyf M, Pakneshan P, Rabbani SA (2004) DNA methylation and breast cancer. Biochem Pharmacol 68:1187–1197. doi:10.1016/j.bcp.2004.04.030
  Article PubMed CAS Google Scholar
• Agrawal A, Murphy RF, Agrawal DK (2007) DNA methylation in breast and colorectal cancers. Mod Pathol 20:711–721. doi:10.1038/modpathol.3800822
  Article PubMed CAS Google Scholar
• Kamachi Y, Uchikawa M, Kondoh H (2000) Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 16:182–187. doi:10.1016/S0168-9525(99)01955-1
  Article PubMed CAS Google Scholar
• Wegner M (1999) From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 27:1409–1420. doi:10.1093/nar/27.6.1409
  Article PubMed CAS Google Scholar
• Kiefer JC (2007) Back to basics: Sox genes. Dev Dyn 236:2356–2366. doi:10.1002/dvdy.21218
  Article PubMed CAS Google Scholar
• Lefebvre V, Dumitriu B, Penzo-Méndez A et al (2007) Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol 39:2195–2214. doi:10.1016/j.biocel.2007.05.019
  Article PubMed CAS Google Scholar
• Dong C, Wilhelm D, Koopman P (2004) Sox genes and cancer. Cytogenet Genome Res 105:442–447. doi:10.1159/000078217
  Article PubMed CAS Google Scholar
• Sohn J, Natale J, Chew LJ, Belachew S et al (2006) Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J Neurosci 26:9722–9735. doi:10.1523/JNEUROSCI.1716-06.2006
  Article PubMed CAS Google Scholar
• Matsui T, Kanai-Azuma M, Hara K et al (2006) Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice. J Cell Sci 119:3513–3526. doi:10.1242/jcs.03081
  Article PubMed CAS Google Scholar
• Park KS, Wells JM, Zorn AM et al (2006) Sox17 influences the differentiation of respiratory epithelial cells. Dev Biol 294:192–202. doi:10.1016/j.ydbio.2006.02.038
  Article PubMed CAS Google Scholar
• Shimoda M, Kanai-Azuma M, Hara K et al (2007) Sox17 plays a substantial role in late-stage differentiation of the extraembryonic endoderm in vitro. J Cell Sci 120:3859–3869. doi:10.1242/jcs.007856
  Article PubMed CAS Google Scholar
• Kim I, Saunders TL, Morrison SJ (2007) Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells. Cell 130:470–483. doi:10.1016/j.cell.2007.06.011
  Article PubMed CAS Google Scholar
• Jang YY, Sharkis SJ (2007) Fetal to adult stem cell transition: knocking Sox17 off. Cell 130:403–404. doi:10.1016/j.cell.2007.07.027
  Article PubMed CAS Google Scholar
• Liu Y, Asakura M, Inoue H et al (2007) Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells. Proc Natl Acad Sci USA 104:3859–3864. doi:10.1073/pnas.0609100104
  Article PubMed CAS Google Scholar
• Sinner D, Kordich JJ, Spence JR et al (2007) Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 27:7802–7815. doi:10.1128/MCB.02179-06
  Article PubMed CAS Google Scholar
• Zhang W, Glöckner SC, Guo M et al (2008) Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 68:2764–2772. doi:10.1158/0008-5472.CAN-07-6349
  Article PubMed CAS Google Scholar
• Zorn AM, Barish GD, Williams BO et al (1999) Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. Mol Cell 4:487–498. doi:10.1016/S1097-2765(00)80200-2
  Article PubMed CAS Google Scholar
• Kanai-Azuma M, Kanai Y, Gad JM et al (2002) Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 129:2367–2379
  PubMed CAS Google Scholar
• de Jong J, Stoop H, Gillis AJ et al (2008) Differential expression of Sox17 and SOX2 in germ cells and stem cells has biological and clinical implications. J Pathol 215:21–30. doi:10.1002/path.2332
  Article PubMed CAS Google Scholar
• Morin PJ, Weeraratna AT (2003) Wnt signaling in human cancer. Cancer Treat Res 115:169–187. doi:10.1007/0-306-48158-8_7
  Article PubMed CAS Google Scholar
• Karim R, Tse G, Putti T et al (2004) The significance of the Wnt pathway in the pathology of human cancers. Pathology 36:120–128. doi:10.1080/00313020410001671957
  Article PubMed CAS Google Scholar
• Brantjes H, Barker N, van Es J et al (2002) Lady justice casting the final verdict on the outcome of Wnt signalling. Biol Chem 383:255–261. doi:10.1515/BC.2002.027
  Article PubMed CAS Google Scholar
• Li Y, Welm B, Podsypanina K et al (2003) Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 100:15853–15858. doi:10.1073/pnas.2136825100
  Article PubMed CAS Google Scholar
• Howe LR, Brown AM (2004) Wnt signaling and breast cancer. Cancer Biol Ther 3:36–41
  PubMed CAS Google Scholar
• Veeck J, Niederacher D, An H et al (2006) Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene 25:3479–3488. doi:10.1038/sj.onc.1209386
  Article PubMed CAS Google Scholar
• Lo PK, Mehrotra J, D’Costa A et al (2006) Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. Cancer Biol Ther 5:281–286
  Article PubMed CAS Google Scholar
• Veeck J, Geisler C, Noetzel E et al (2008) Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis. Carcinogenesis 29:991–998. doi:10.1093/carcin/bgn076
  Article PubMed CAS Google Scholar
• Ai L, Tao Q, Zhong S et al (2006) Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis 27:1341–1348. doi:10.1093/carcin/bgi379
  Article PubMed CAS Google Scholar
• Suzuki H, Toyota M, Carraway H et al (2008) Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 98:1147–1156. doi:10.1038/sj.bjc.6604259
  Article PubMed CAS Google Scholar
• Akiyama H, Lyons JP, Mori-Akiyama Y et al (2004) Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18:1072–1087. doi:10.1101/gad.1171104
  Article PubMed CAS Google Scholar
• Takash W, Cañizares J, Bonneaud N et al (2001) SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res 29:4274–4283. doi:10.1093/nar/29.21.4274
  Article PubMed CAS Google Scholar
• Sinner D, Rankin S, Lee M et al (2004) Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes. Development 131:3069–3080. doi:10.1242/dev.01176
  Article PubMed CAS Google Scholar
• Katoh M (2002) Molecular cloning and characterization of human Sox17. Int J Mol Med 9:153–157
  PubMed CAS Google Scholar
• Feltus FA, Lee EK, Costello JF et al (2004) Predicting aberrant CpG island methylation. Proc Natl Acad Sci USA 100:12253–12258. doi:10.1073/pnas.2037852100
  Article CAS Google Scholar
• Ushijima T (2005) Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5:23–31. doi:10.1038/nrc1571
  Article CAS Google Scholar
• Kimelman D, Xu W (2006) Beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 25:7482–7491. doi:10.1038/sj.onc.1210055
  Article PubMed CAS Google Scholar
• Lin SY, Xia W, Wang JC et al (2000) Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97:4262–4266. doi:10.1073/pnas.060025397
  Article PubMed CAS Google Scholar
• Turashvili G, Bouchal J, Burkadze G et al (2006) Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology 73:213–223. doi:10.1159/000098207
  Article PubMed CAS Google Scholar
• Dolled-Filhart M, McCabe A, Giltnane J et al (2006) Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res 66:5487–5494. doi:10.1158/0008-5472.CAN-06-0100
  Article PubMed CAS Google Scholar
• Candidus S, Bischoff P, Becker KF et al (1996) No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. Cancer Res 56:49–52
  PubMed CAS Google Scholar
• Kawano Y, Kypta R (2003) Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116:2627–2634. doi:10.1242/jcs.00623
  Article PubMed CAS Google Scholar